title: Long-standing malignant pancreatic carcinoid treated with octreotide.
abstract: A male presented with a metastatic, plasma serotonin-secreting (high 5-HIAA in urine), malignant pancreatic carcinoid with a carcinoid-like syndrome, and was assessed using ultrasounds (US), computerized tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography (EUS) and Octreoscan; he sequentially received chemotherapy, interferon and octreotide, with long-term, 12-year survival after diagnosis. Given this unusual case, the second reported in our country, the overall literature is reviewed.
authors.affiliation: Unidad de Ecoendoscopia y Eco-Doppler, Centro Médico Teknon, Barcelona, Spain. varas@dr.teknon.es
authors.forename: M J
authors.initials: MJ
authors.lastname: Varas-Lorenzo
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002276:Carcinoid Tumor / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide